The latest article in the NY Times Being a Patient series describes the reasons and ways 20- and 30-somethings get meds after determining that they need them. Particularly for mental health problems, the people featured question psychiatrists’ expertise. The rely on their experiences and stories…
With news media reporting abundant bad news about big drug companies, it’s not surprising to learn that profits are falling. The FDA is moving more slowly than in recent years and blocking drugs that would likely have been accepted under previous practices. Doctors are prescribing…
This has been all over the news, but in case you haven’t seen it, the FDA has issued a warning on Ortho Evra, aka “the patch.” It releases higher level of hormones than previously reported, which puts women at higher risk for blood clots and…
The FDA has given Boston Scientific approval to begin a trial of occipital nerve stimulation for migraine. The specific device that will be studied is called Precision, which is the smallest rechargeable stimulator available. The study, which is being called PRISM (Precision implantable stimulator for…
Many drug ads and health public service messages unintentionally design advertising that is ineffective or harmful, according to a recent study at Indiana University. However, an earlier study contradicts these findings. (Via Kaiser Network‘s Daily Health Policy Report; Studies Show Mixed Results for Effects of…